Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
CCD
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "CCD" in MCE Product Catalog:
Category:
Target:
Cat. No.: HY-P990114
Target:
Research Areas:
Cat. No.: HY-169369
CAS No.: 3109600-48-5
Synonyms: XJZ-06-462
TRAP-1 (XJZ-06-462) is a non-covalent regulated induced proximity targeting chimera (RIPTAC) with JQ-1 carboxylic acid (HY-78695) as its target protein ligand. TRAP-1 forms a ternary complex with p53 Y220C and BRD4, potently activates p53 transcription, and inhibits the growth and proliferation of tumor cells. TRAP-1 upregulates p21 and other p53 target genes in pancreatic cell lines carrying p53 Y220C, and induces cellular senescence and apoptosis. TRAP-1 can be used in cancer research involving p53 Y220C-carrying tumors .
Cat. No.: HY-RS12351
Target:
Research Areas:
RUNX2 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Target:
Research Areas:
BDM-2 is an IN-LEDGF allosteric inhibitor (INLAI) of HIV-1 integrase (IN refers to integrase) (IC50=47 nM) with potent anti-Retroviral (ARV) activity. BDM-2 shows IN multimerization activation effect with an AC50 value of 20 nM. BDM-2 blocks the interaction between the catalytic core domain of IN (IN-CCD) and the Integrase binding domain of LEDGF/p75 (IBD), with an IC50 value of 0.15 μM. BDM-2 exhibits highly selective and favorable cytotoxicity .
Cat. No.: HY-160281
CAS No.: 2271351-19-8
Target:
Research Areas:
CCD-2 is a conventional detergent and is readily degraded. CCD-2 can efficiently solubilize and stabilize diverse G protein-coupled receptors (GPCRs). CCD-2 is amenable to the β-barrel protein research. The chemical cleavage of CCD-2 is rapid, complete and biorthogonal and should facilitate a chemical methodology for in situ detergent replacement in diverse membrane proteins (MPs) studies .
Cat. No.: HY-125508
CAS No.: 162883-07-0
Target:
Research Areas:
CCD-3693 is an orally active GABA receptor agonist. CCD-3693 has anxiolytic, anticonvulsant and sedative hypnotic activities and can be used in research related to neurological diseases .
Cat. No.: HY-168382
CAS No.: 98103-46-9
Research Areas:
5R(6S)-EET is the metabolite of Arachidonic acid (HY-109590). 5R(6S)-EET activates the synthesis of endogenous prostaglandin (PGE2), which inhibits the Na + absorption, increases the intracellular Ca 2+, and promotes the depolarization of transmembrane voltage. 5R(6S)-EET exhibits stereoselectivity with less effectness than 5S(6R)-EET (HY-168382A) .
Cat. No.: HY-168382A
CAS No.: 98103-47-0
Research Areas:
5S(6R)-EET is the metabolite of Arachidonic acid (HY-109590). 5S(6R)-EET activates the synthesis of endogenous prostaglandin (PGE2), which inhibits the Na + absorption, increases the intracellular Ca 2+, and promotes the depolarization of transmembrane voltage. 5S(6R)-EET is more active than 5R(6S)-EET (HY-168382) .
Cat. No.: HY-12210
CAS No.: 957889-73-5
Target:
Research Areas:
(S)-BI-1001 (Compound 11) is an active S-enantiomer of BI-1001. (S)-BI-1001 exhibits antiviral potency against HIV-1 integrase with an IC50 of 28 nM, an EC50 of 450 nM and a Kd of 4.7 μM .
Cat. No.: HY-162721
Target:
Research Areas:
Anticancer agent 242 (7) possesses anticancer activity in A2780 (IC50 = 0.24 μM, ovarian adenocarcinoma), A2780cis (IC50 = 0.45 μM, resistant derivative of A2780), CCD18Co (IC50 = 0.59 μM, non-malignant human fibroblasts), A549 (IC50 = 0.32 μM, lung carcinoma), HT29 (IC50 = 0.26 μM, colorectal adenocarcinoma), and MCF7 (IC50 = 0.55 μM, breast adenocarcinoma) .
Cat. No.: HY-183926
CAS No.: 384361-09-5
Target:
Research Areas:
D719 is an HIV-1 integrase inhibitor. D719 binds to the hydrophobic pocket of HIV-1 integrase CCD dimer, disrupts interaction with LEDGF/P75, and prevents integrase nuclear translocation. D719 reduces HIV-1 p24 antigen production in acute infection of human T cells. D719 can be used for the research of HIV infection .
Cat. No.: HY-P86862
Synonyms: Activated protein C receptor antibody; APC receptor antibody; APCR antibody; bA42O4.2 antibody; CCCA antibody; CCD41 antibody; CD201 antibody; CD201 antigen antibody; cell cycle, centrosome-associated protein antibody; Cell cycle, centrosome-associated protein antibody; Activated protein C receptor antibody; APC receptor antibody; APCR antibody; bA42O4.2 antibody; CCCA antibody; CCD41 antibody; CD201 antibody; CD201 antigen antibody; cell cycle, centrosome-associated protein antibody; Cell cycle, centrosome-associated protein antibody; centrocyclin antibody; Endothelial cell protein C receptor antibody; Endothelial protein C receptor antibody; EPCR antibody; EPCR_HUMAN antibody; MGC23024 antibody; PROCR antibody; Protein C receptor, endothelial antibody;
Cat. No.: HY-N18192
CAS No.: 88524-65-6
Category:
Target:
Cat. No.: HY-138794G
CAS No.: 2417089-74-6
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
